ATE361977T1 - In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen - Google Patents

In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen

Info

Publication number
ATE361977T1
ATE361977T1 AT00935435T AT00935435T ATE361977T1 AT E361977 T1 ATE361977 T1 AT E361977T1 AT 00935435 T AT00935435 T AT 00935435T AT 00935435 T AT00935435 T AT 00935435T AT E361977 T1 ATE361977 T1 AT E361977T1
Authority
AT
Austria
Prior art keywords
pancreatic
pharmaceutical compositions
tissues
vitro method
hormone production
Prior art date
Application number
AT00935435T
Other languages
English (en)
Inventor
Sarah Ferber
Original Assignee
Sarah Ferber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sarah Ferber filed Critical Sarah Ferber
Application granted granted Critical
Publication of ATE361977T1 publication Critical patent/ATE361977T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00935435T 1999-06-01 2000-06-01 In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen ATE361977T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13714399P 1999-06-01 1999-06-01
US19853200P 2000-04-19 2000-04-19
US09/584,216 US6774120B1 (en) 1999-06-01 2000-05-31 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

Publications (1)

Publication Number Publication Date
ATE361977T1 true ATE361977T1 (de) 2007-06-15

Family

ID=27384964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935435T ATE361977T1 (de) 1999-06-01 2000-06-01 In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen

Country Status (8)

Country Link
US (3) US6774120B1 (de)
EP (1) EP1180143B1 (de)
JP (2) JP2003500457A (de)
AT (1) ATE361977T1 (de)
AU (1) AU779619B2 (de)
CA (1) CA2371995C (de)
DE (1) DE60034781T2 (de)
WO (1) WO2000072885A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778899B2 (en) 1999-06-01 2014-07-15 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US6774120B1 (en) 1999-06-01 2004-08-10 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US7567870B1 (en) * 2000-07-31 2009-07-28 Institute For Systems Biology Multiparameter analysis for predictive medicine
JP2004526449A (ja) 2001-03-29 2004-09-02 イクシオン・バイオテクノロジー・インコーポレーテッド 非膵性幹細胞の膵分化経路への分化転換法
US7343247B2 (en) * 2001-07-30 2008-03-11 The Institute For Systems Biology Methods of classifying drug responsiveness using multiparameter analysis
WO2003033697A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
CN101240262A (zh) 2001-12-07 2008-08-13 杰龙公司 源自人胚胎干细胞的胰岛细胞
US20030109038A1 (en) 2001-12-07 2003-06-12 Thies R. Scott Chondrocyte precursors derived from human embryonic stem cells
JP2003189875A (ja) * 2001-12-28 2003-07-08 Japan Science & Technology Corp 膵β細胞関連転写因子の遺伝子導入によるインスリン産生細胞の形成誘導
GB0206357D0 (en) * 2002-03-18 2002-05-01 Univ Bath Cells
JP4136434B2 (ja) * 2002-04-17 2008-08-20 進 清野 インスリン産生細胞の誘導
GB0300208D0 (en) * 2003-01-06 2003-02-05 Oxford Biomedica Ltd Insulin producing cells
AU2004232858B2 (en) 2003-04-23 2009-07-09 Mannkind Corporation Hydraulically actuated pump for long duration medicament administration
WO2004098646A1 (en) * 2003-05-12 2004-11-18 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
WO2005083059A1 (en) * 2004-02-23 2005-09-09 University Of Florida Compositions and methods for making insulin-producing cells
WO2006014425A1 (en) 2004-07-02 2006-02-09 Biovalve Technologies, Inc. Methods and devices for delivering glp-1 and uses thereof
WO2006010531A1 (en) * 2004-07-28 2006-02-02 F. Hoffmann-La Roche Ag Prohormone convertase i as target/marker for beta cell failure
US9056093B2 (en) * 2005-01-07 2015-06-16 Wake Forest University Health Sciences Regeneration of pancreatic islets by amniotic fluid stem cell therapy
JP2007061096A (ja) * 2005-08-31 2007-03-15 Lifescan Inc 細胞分化を促進する方法
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
ATE498005T1 (de) * 2005-12-21 2011-02-15 Univ Catholique Louvain Isolierte leberstammzellen
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
AU2007233231B2 (en) 2006-03-30 2011-02-24 Mannkind Corporation Multi-cartridge fluid delivery device
JP5386350B2 (ja) 2006-05-31 2014-01-15 タケダ カリフォルニア インコーポレイテッド グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体
WO2007149182A2 (en) 2006-06-19 2007-12-27 Geron Corporation Differentiation and enrichment of islet-like cells from human pluripotent stem cells
JP5419706B2 (ja) 2006-12-20 2014-02-19 タケダ カリフォルニア インコーポレイテッド グルコキナーゼアクチベーター
WO2008116107A2 (en) 2007-03-21 2008-09-25 Takeda San Diego, Inc. Piperazine derivatives as glucokinase activators
CN102154210A (zh) * 2010-12-28 2011-08-17 沈达青 一种胰岛素基因修饰的肝干细胞制法及其应用和制剂
BR112015031253B1 (pt) 2013-06-13 2021-09-28 Orgenesis Ltd. Método para produção de uma população de células transdiferenciada
DK3016665T3 (da) 2013-07-05 2019-11-25 Univ Catholique Louvain Konditioneret medium fra humane voksne leverstamceller og dets anvendelse i behandlingen af leverlidelser
MA41296A (fr) 2014-12-30 2017-11-07 Orgenesis Ltd Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
WO2018207179A1 (en) 2017-05-08 2018-11-15 Orgenesis Ltd. Transdifferentiated cell populations and methods of use thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4980286A (en) * 1985-07-05 1990-12-25 Whitehead Institute For Biomedical Research In vivo introduction and expression of foreign genetic material in epithelial cells
US4737323A (en) * 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
ATE141646T1 (de) 1986-04-09 1996-09-15 Genzyme Corp Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5427940A (en) * 1991-06-03 1995-06-27 Board Of Regents, The University Of Texas System Engineered cells producing insulin in response to glucose
PT671923E (pt) 1992-10-09 2001-10-30 Advanced Tissue Sciences Inc Celulas de reserva do figado
US5424286A (en) * 1993-05-24 1995-06-13 Eng; John Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
EP0714438B1 (de) 1993-08-16 2007-09-19 RESEARCH DEVELOPMENT FOUNDATION (a Nevada corporation) Ein homeobox-faktor der insulin-expression in pankreatischen inselnzellen stimuliert
US5858973A (en) 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US5849989A (en) 1994-10-07 1998-12-15 Ontogeny, Inc. Insulin promoter factor, and uses related thereto
ATE321880T1 (de) * 1995-11-30 2006-04-15 Res Dev Foundation Nachweisverfahren für verbindungen, welche die somatostatin- und insulinproduktion stimulieren
EP0929573A1 (de) * 1996-06-24 1999-07-21 Vivorx Pharmaceuticals, Inc. Methoden für die isolierung und vermehrung von insulin-sekretierenden zellen.
EP0996736A1 (de) * 1997-08-11 2000-05-03 Chiron Corporation Verfahren zur genetischen veränderung von t-zellen
US6242666B1 (en) * 1998-12-16 2001-06-05 The Scripps Research Institute Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
US6774120B1 (en) 1999-06-01 2004-08-10 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US6759039B2 (en) * 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
WO2003033697A1 (en) 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
JP4136434B2 (ja) * 2002-04-17 2008-08-20 進 清野 インスリン産生細胞の誘導
WO2004098646A1 (en) 2003-05-12 2004-11-18 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

Also Published As

Publication number Publication date
EP1180143B1 (de) 2007-05-09
US6774120B1 (en) 2004-08-10
US20120329710A1 (en) 2012-12-27
AU779619B2 (en) 2005-02-03
AU5097400A (en) 2000-12-18
WO2000072885A9 (en) 2001-03-01
US8119405B2 (en) 2012-02-21
JP2003500457A (ja) 2003-01-07
CA2371995A1 (en) 2000-12-07
JP2011057716A (ja) 2011-03-24
WO2000072885A2 (en) 2000-12-07
CA2371995C (en) 2014-01-21
DE60034781T2 (de) 2008-01-17
EP1180143A2 (de) 2002-02-20
US20040213769A1 (en) 2004-10-28
WO2000072885A3 (en) 2001-05-10
DE60034781D1 (de) 2007-06-21

Similar Documents

Publication Publication Date Title
DE60034781D1 (de) In vitro verfahren zur induzierung der regulierten pankreatische-hormon produktion in nicht-pankreatischen inselngeweben, damit verbundene pharmazeutische zusammenseztzungen
DE602005018043D1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
ATE276764T1 (de) Camptothecin arzneimittelkombinationen mit verringerten nebenwirkungen
AU2003205315A1 (en) Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
GB2352395A (en) Paroxetine methanesulfonate
MY124214A (en) Compositions for promoting crowth
PT1011632E (pt) Composicao farmaceutica para o tratamento de dismenorreia e parto prematuro
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
IL151628A0 (en) Combination therapies with vascular damaging activity
DE60025905D1 (de) In vitro methode zur synchronisation von oozytenreifung
SE9603725D0 (sv) New teatment
DE60332721D1 (de) Verfahren und zusammensetzung zur erhöhung der absorption und der bioverfügbarkeit von hydrophoben wirkstoffen im magen-darmtrakt
DK1189627T3 (da) Sammensætninger indeholdende opløselige former af HLA-G til behandling af inflammatoriske patologiske tilstande i huden
DK1549329T3 (da) Ekstrakt med antitumoraktivitet og anti-giftaktivitet
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
DE60217315D1 (de) Pharmazeutische zusammensetzungen von rapamycines
BR0212834A (pt) Formulações e uso das mesmas
DE60032993D1 (de) Vorrichtung zur kardioplegie-verabreichung
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
ATE259659T1 (de) Zusammensetzung die mindestens ein stickstoffmonoxid-synthase inhibitor und mindestens ein phospholipase a2 inhibitor enthält zur herstellung eines medikamentes
FI19992511L (fi) Ravintoainekoostumukset ja menetelmä niiden valmistamiseksi
DE60044708D1 (de) Pyridinverbindungen, ihre verfahren zur herstellung und anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties